Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02210208 · ClinicalTrials.gov registry record · NA
A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.
A NA study, sponsored by Molnlycke Health Care AB.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02210208 is a NA study that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 25 participants.
The verdict
NCT02210208, a NA study, has completed, sponsored by Molnlycke Health Care AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Part A The primary objective of Part A will be to verify performance and safety of Mepitel® Ag, a meshed, non- adherent soft silicone wound contact layer containing silver in the treatment of skin grafts in surgical burn patients. Part B The primary objective of Part B will be to examine the usefulness of Mepilex® Transfer Ag as an adequate option for donor site healing.
Interventions
- DEVICE Mepitel® Ag
- DEVICE Mepilex® Transfer Ag
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02210208
The ClinicalTrials.gov registry entry for NCT02210208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mepitel® Ag is the first listed.
NCT02210208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02210208 about?
NCT02210208 is a clinical study titled "A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.". Part A The primary objective of Part A will be to verify performance and safety of Mepitel® Ag, a meshed, non- adherent soft silicone wound contact layer containing silver in the treatment of skin grafts in surgical burn patients. Part B The primary objective of Part B will be to examine the useful...
What is the current status of trial NCT02210208?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2014-09. Estimated completion is 2016-06-15.
What interventions are being tested in trial NCT02210208?
The interventions under investigation include: Mepitel® Ag (DEVICE), Mepilex® Transfer Ag (DEVICE).
Who is sponsoring clinical trial NCT02210208?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.